Recent advances in the cervical screening programme

Research output: Contribution to journalComment/debatepeer-review


The UK National Screening Committee recommended high-risk human papillomavirus (hrHPV) primary screening in 2016, and it was introduced in England 3 years later, to increase the test sensitivity for cervical intraepithelial neoplasia, reducing the risk of developing cervical cancer. The 2018 call by the World Health Organization to eliminate cervical cancer as a public health measure supports primary HPV screening as both clinically effective and cost effective. In this commentary, we review the emerging evidence from primary HPV screening as pilot and replacement programmes establish themselves globally.
Original languageEnglish
Pages (from-to)131-134
Number of pages1
JournalBJOG: An International Journal of Obstetrics Gynaecology
Issue number2
Early online date6 Oct 2022
Publication statusPublished - Jan 2023


Dive into the research topics of 'Recent advances in the cervical screening programme'. Together they form a unique fingerprint.

Cite this